TL;DR
Yes: A review article published in the journal Clinical Obesity in 2026, analyzing data from 480,825 adults, shows that users of GLP-1 medications such as Ozempic, Wegovy, and Mounjaro have an increased risk of micronutrient deficiencies—primarily in vitamin D, magnesium, calcium, iron, and potassium. The cause is not the drug itself, but the significantly reduced food intake due to appetite suppression. Targeted nutrient supplementation can lower this risk.
Do weight loss injections cause nutrient deficiencies?
Yes, according to current data, the risk is real and increases with the duration of use. The most comprehensive review to date on this topic by Urbina, Salinas-Ruiz, Valenciano, and Clapp, published in 2026 in Clinical Obesity, evaluated six studies with a total of 480,825 adult GLP-1 users. Result: A vitamin D deficiency occurred in 7.5% of users after six months, rising to 13.6% after twelve months.
Over 60% of the individuals evaluated consumed less calcium and iron than recommended. Average dietary vitamin D intake was only about 20% of the recommended amount. Magnesium, potassium, and vitamins B1 (thiamine) and B12 were also affected, with B12 deficits increasing over the duration of use.
Why GLP-1 medications alter nutrient levels
The mechanism is quantity-related, not toxic. Semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro) delay gastric emptying and dampen the sensation of hunger via GLP-1 or GLP-1/GIP receptors in the brain. Anyone who eats significantly less automatically consumes fewer vitamins and minerals through their diet, regardless of how healthy their remaining intake is.
This mechanic is similar to the situation following bariatric surgery, where clinical nutritionists have been using structured supplementation plans for years. Sibal, Balamurugan, Langley, Graham, and Mahawar (Nutrients, 2025) investigated this exact transferability and recommend an analogous approach for GLP-1 users: regularly check nutrient status and supplement in a targeted rather than general manner.
Which nutrients are most frequently affected according to research?
The following overview summarizes the most frequently documented deficits in the review by Urbina et al. (2026).
| Nutrient | Findings according to research | Possible consequence of deficiency |
|---|---|---|
| Vitamin D | Intake ø ~20% of recommendation; deficiency in 7.5–13.6% of users | Fatigue, weakened immune system, bone metabolism |
| Calcium | >60% below reference value | Contributes to muscle mass loss alongside protein deficiency |
| Iron | >60% below reference value | Exhaustion, paleness, reduced performance |
| Magnesium & Potassium | Intake documented below reference levels | Muscle cramps, exhaustion, electrolyte balance |
| Vitamin B1 & B12 | Deficits increase with duration of use | Nerve function, energy metabolism |
For those who want to understand vitamin D requirements—regardless of weight loss injections—detailed daily dosages can be found in our article Vitamin D3 dosage: How many IU per day actually make sense. Furthermore, Vitamin D3 K2 drops are easier to dose than capsules, which can be practical when food intake is reduced.
Muscle loss while on weight loss injections: Why protein intake is crucial
Yes, a portion of the weight loss during GLP-1 therapy involves muscle mass, not just fat tissue. According to the review by Urbina et al., insufficient protein and calcium intake contributes directly to this loss of lean mass. This is relevant because muscle mass supports metabolic rate and helps in maintaining weight after therapy ends.
Nutritional recommendations from the bariatric field, which Sibal et al. applied to GLP-1 users, highlight sufficient protein intake, spread throughout the day, as the single most important measure against this effect—especially when eating is limited and every meal counts.
Practical tip
With a significantly reduced appetite, a whey protein powder is often more practical than a large portion of protein-rich whole foods. You can read more about sensible protein quantities during weight loss in our article Protein for weight loss.
Practical supplementation strategy
The following steps are based on current data and recognized monitoring approaches from bariatric clinical nutrition—they do not replace individual medical advice.
- Have your nutrient status checked. A blood test before and during therapy reveals which levels are actually low, rather than supplementing arbitrarily.
- Supplement vitamin D in a targeted manner. Since dietary intake averages only about 20% of the recommendation according to research, baseline supplementation, e.g., via Vitamin D3 K2 drops, is a sensible approach.
- Keep an eye on magnesium and iron. Both minerals show insufficient levels in the review; products like Magnesium Bisglycinate or Iron Bisglycinate can be introduced at low doses and adjusted based on blood test results.
- Supplement electrolytes if fluid intake is reduced. Those who eat less often consume less potassium and sodium through solid food; a sugar-free electrolyte powder can compensate for this if needed.
- Prioritize protein to maintain muscle mass. See the section above.
- Consider broad protection. A proven multivitamin supplement can serve as a safety net, but does not replace targeted intake in the event of a confirmed deficiency.
Expert Perspectives & Protocol Breakdown
Urbina et al. follow a broad epidemiological review approach: They combine six studies involving 480,825 participants to estimate population-wide prevalence of individual nutrient deficiencies during GLP-1 therapy, without testing an intervention or supplementation strategy themselves.
Sibal et al., conversely, follow a transfer-based approach: They use long-established monitoring and supplementation protocols from bariatric surgery as a template to derive concrete, actionable recommendations for GLP-1 users, rather than collecting new prevalence data. For consumers, the comparison means: Urbina et al. show the statistical magnitude of the problem, while Sibal et al. show which established procedures can contribute to the solution.
Limitations of the research
The underlying review is based primarily on observational data, not randomized-controlled trials on supplementation itself. Individual differences in baseline status, diet, therapy duration, and dosage are significant. The percentages mentioned stem from international cohorts and cannot be applied 1:1 to every individual. Nutrient supplementation during GLP-1 therapy should therefore always be coordinated with the treating physician or a nutrition professional, ideally based on a blood test.
Frequently asked questions about weight loss injections and nutrient deficiency
Which vitamin is most frequently missing when taking Ozempic or Wegovy?
According to the review by Urbina et al. (2026), vitamin D is the most frequently affected: Dietary intake reaches an average of only 20% of the recommended amount, and a deficiency was identified in up to 13.6% of users after twelve months.
Must I automatically take supplements when using a weight loss injection?
Not automatically, but the risk increases with the duration of use and the amount of reduced food intake. A blood test before starting and during therapy shows if and which targeted supplementation is sensible.
Why do I also lose muscle mass during GLP-1 therapy?
Because a reduced total food intake often also supplies less protein and calcium—both nutrients that research shows are directly linked to maintaining lean mass.
Does a supplement replace medical supervision?
No. Supplements can bridge a confirmed or probable gap but cannot replace medical follow-up during GLP-1 therapy.
Conclusion
Current research shows a real risk of micronutrient deficiencies during GLP-1 therapy that increases with the duration of use—especially regarding vitamin D, calcium, iron, and magnesium, as well as protein for muscle maintenance. A blood test and targeted, aligned nutrient intake are a more sensible approach than general supplementation.
References & Scientific Citations
- Urbina, J., Salinas-Ruiz, L. E., Valenciano, C. & Clapp, B. (2026). Micronutrient and Nutritional Deficiencies Associated With GLP-1 Receptor Agonist Therapy: A Narrative Review, Clinical Obesity
- Sibal, R., Balamurugan, G., Langley, J., Graham, Y. & Mahawar, K. (2025). Macronutrient, Micronutrient Supplementation and Monitoring for Patients on GLP-1 Agonists: Can We Learn from Metabolic and Bariatric Surgery?, Nutrients
Read more
- Vitamin D3 dosage: How many IU per day actually make sense
- Magnesium intake: Dosage, best time, and the right form
- Iron for women: Requirements, dosage, and signs of deficiency
- Sugar-free electrolyte powder: Is it really worth it?
- Protein for weight loss: What studies really show
- Multivitamins: Who really benefits and when they are unnecessary
